Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 04:46 am EDT
Share
Guizhou Salvage Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 576.15 million compared to CNY 440.2 million a year ago. Revenue was CNY 576.15 million compared to CNY 440.2 million a year ago. Net loss was CNY 87.05 million compared to net income of CNY 30.87 million a year ago. Basic loss per share from continuing operations was CNY 0.0514 compared to basic earnings per share from continuing operations of CNY 0.0182 a year ago. Diluted loss per share from continuing operations was CNY 0.0514 compared to diluted earnings per share from continuing operations of CNY 0.0182 a year ago.
Guizhou Chitianhua Co Ltd, formerly Guizhou Salvage Pharmaceutical Co Ltd, is a China-based company mainly engaged in chemical production and pharmaceutical production. The chemical business mainly includes the production and sales of urea, methanol and compound fertilizer. The pharmaceutical manufacturing business mainly includes the production and sales of pharmaceuticals and medical devices. The Company's pharmaceutical products include diabetes drugs, cardiovascular drugs, dermatology drugs, gynecological drugs, digestive system drugs, endocrine drugs, psychotropic drugs, among others. The Company mainly conducts businesses within the domestic market.